PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES

Show other versions (1)
Bibliographic Details
Main Authors: Barnes, E, Antonella, F, Aston, S, Smith, K, Brown, A, Capone, S, Ambrosio, M, Harrison, G, Ammendola, V, Bartiromo, M, Traboni, C, Siani, L, Sparacino, A, Naddeo, M, Colloca, S, Cortese, R, Nicosia, A, Klenerman, P
Format: Conference item
Published: 2009

Similar Items